Type 1 diabetes (T1D) affects over 300,000 Canadians. It’s an autoimmune disease where the pancreas doesn’t produce insulin, the hormone that helps the body to control glucose (sugar) levels in the bloodstream. Without insulin, glucose builds up in the blood instead of being used for energy. If left untreated, this results in significant complications and eventual death. There is no cure and people with T1D must inject themselves with artificial insulin; either by injection or pump, often several times a day.
For over 40 years, JDRF has been a global leader in the drive towards a cure for T1D, through both research funding and advocacy. JDRF also provides support to living with T1D today to live healthier, easier, and safer lives.
JDRF’s goal is to progressively diminish the impact of this disease until there is world free from T1D. Power Corporation has supported the JDRF since 1988. 2021 marks the 100th anniversary of the discovery of insulin, and JDRF will be commemorating the milestone with a significant push towards accelerating research towards a cure.
Canadians live with Type 1 Diabetes (T1D)
invested in T1D research in Canada in 2019
cutting edge projects and clinical trials supported in Canada
raised by the JDRF House ParT1D for a Cure in 2020 to accelerate research